ATE267828T1 - Dipyridoimidazolderivate zur behandlung von störungen des zentralen nervensystems - Google Patents

Dipyridoimidazolderivate zur behandlung von störungen des zentralen nervensystems

Info

Publication number
ATE267828T1
ATE267828T1 AT98953243T AT98953243T ATE267828T1 AT E267828 T1 ATE267828 T1 AT E267828T1 AT 98953243 T AT98953243 T AT 98953243T AT 98953243 T AT98953243 T AT 98953243T AT E267828 T1 ATE267828 T1 AT E267828T1
Authority
AT
Austria
Prior art keywords
derivatives
dipyridoimidazole
treatment
nervous system
central nervous
Prior art date
Application number
AT98953243T
Other languages
English (en)
Inventor
Bruce E Maryanoff
David Mccomsey
James Mcnally
Samuel O Nortey
Allen B Reitz
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE267828T1 publication Critical patent/ATE267828T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT98953243T 1997-10-07 1998-10-05 Dipyridoimidazolderivate zur behandlung von störungen des zentralen nervensystems ATE267828T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6124897P 1997-10-07 1997-10-07
PCT/US1998/020802 WO1999018105A1 (en) 1997-10-07 1998-10-05 Dipyridoimidazolderivatives useful in treating central nervous system disorders

Publications (1)

Publication Number Publication Date
ATE267828T1 true ATE267828T1 (de) 2004-06-15

Family

ID=22034585

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98953243T ATE267828T1 (de) 1997-10-07 1998-10-05 Dipyridoimidazolderivate zur behandlung von störungen des zentralen nervensystems

Country Status (11)

Country Link
US (1) US5968946A (de)
EP (1) EP1023291B1 (de)
JP (1) JP2001519351A (de)
AT (1) ATE267828T1 (de)
AU (1) AU1066499A (de)
CA (1) CA2305342A1 (de)
DE (1) DE69824195T2 (de)
DK (1) DK1023291T3 (de)
ES (1) ES2221996T3 (de)
PT (1) PT1023291E (de)
WO (1) WO1999018105A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02001308A (es) 1999-08-02 2004-07-16 Johnson & Johnson Derivados de pirido (1, 2-a)bencimidazol sustituidos en el anillo c-6 utiles en el tratamiento de trastornos del sistema nervioso central.
WO2001092257A1 (en) * 2000-05-26 2001-12-06 Neurogen Corporation Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands
EP1673087B1 (de) 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy-substituierte imidazochinoline
MXPA06003951A (es) * 2003-10-07 2006-06-27 Renovis Inc Derivados de amida como ligandos del canal de ion y composiciones farmaceuticas y sus metodos de uso.
EP1687307B1 (de) 2003-11-25 2016-01-06 3M Innovative Properties Company Substituierte imidazoringsysteme und verfahren
AU2004312510A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
WO2006084251A2 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
CA2600933A1 (en) * 2005-02-28 2006-09-08 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
US7576099B2 (en) * 2005-02-28 2009-08-18 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
JP2010520875A (ja) * 2007-03-09 2010-06-17 レノビス, インコーポレイテッド P2x7調節因子としてのビシクロヘテロアリール化合物およびその使用
JP6928615B2 (ja) * 2016-12-06 2021-09-01 日本化薬株式会社 3−(ピリジル−2−アミノ)プロピオニトリル及びその類縁体の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT656002E (pt) * 1992-08-19 2001-02-28 Mcneilab Inc Derivados de 3-oxo-pirido-1-(1,2a)-benzimidazolo-4-carboxilo e 4-oxo-azepino-(1,2a)-benzimidazolo-5-carboxilo utilizados no tratamento de disturbios do sistema nervoso central
JP2001501949A (ja) * 1996-10-07 2001-02-13 オーソ―マクニール・フアーマシユーチカル・インコーポレーテツド 中枢神経系疾患を処置することに有用な5―ヘテロ原子を含有するアルキル置換された―3―オキソ―ピリド(1,2―a)ベンゾイミダゾール―4―カルボキサミド誘導体

Also Published As

Publication number Publication date
EP1023291B1 (de) 2004-05-26
DE69824195D1 (de) 2004-07-01
WO1999018105A8 (en) 1999-06-10
US5968946A (en) 1999-10-19
EP1023291A1 (de) 2000-08-02
DE69824195T2 (de) 2005-06-23
PT1023291E (pt) 2004-09-30
CA2305342A1 (en) 1999-04-15
AU1066499A (en) 1999-04-27
WO1999018105A1 (en) 1999-04-15
JP2001519351A (ja) 2001-10-23
ES2221996T3 (es) 2005-01-16
DK1023291T3 (da) 2004-10-04

Similar Documents

Publication Publication Date Title
NO995006D0 (no) Nye forbindelser
MY118163A (en) Aryl fused azapolycyclic compounds
NO20000311D0 (no) Nye forbindelser
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
IL114003A (en) 1,4,6-Trisubstituted 1H-pyrrolo[2,3-b]pyridine and 1-H-pyrazolo[3,4-b] pyridine derivatives and pharmaceutical compositions containing them and some intermediates for their preparation
BG101806A (bg) Индолови производни като антагонисти на 5-нт рецептори
BR9901491A (pt) 7-hetero-biciclo [2.2.1] - heptanos.
NO20002788D0 (no) Nye forbindelser
ATE377592T1 (de) Neurotropische substituierte pyrimidine
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
DE60232029D1 (de) N-ä1h-indol-5-ylünaphthalin-1-sulphonamid-derivate und verwandte verbindungen als serotonin 5-ht6 rezeptor antagonisten zur behandlung von erkrankungen des zentralen nervensystems
DE69804966D1 (de) Neue verbindungen
ATE267828T1 (de) Dipyridoimidazolderivate zur behandlung von störungen des zentralen nervensystems
DK0644878T3 (da) 2,5-Dioxo-2,5-dihydro-1H-benz[b[azepiner som NDMA-receptor-antagonister
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
SE9702563D0 (sv) Compounds
IT1276167B1 (it) Imidazo(1,2-alfa)chinossalin-4-ammine attivi come antagonisti adenosinici,procedimento per la loro preparazione e loro composizioni
DE69329654D1 (de) 3-oxo-pyrido [1,2-a] benzimidazol-4-carboxyl und 4-oxo-azepino [1,2-a] benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
SE0100297D0 (sv) New compounds
BR0010748A (pt) Compostos heterocìclicos contendo imidazo, suas composições e usos
ES2167569T3 (es) Uso de imidazo(1,5-a)quinolonas como agentes neuroprotectores.
MX9804631A (es) Antagonistas quinazolin-4-ona del ampa.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1023291

Country of ref document: EP

REN Ceased due to non-payment of the annual fee